Adults with type 1 diabetes who used a GLP-1 receptor agonist or other incretin-based drug had lower risk for all-cause ...

After nonfatal myocardial infarction or stroke, initiation of a GLP-1 receptor agonist was linked to reduced risk for all-cause and CV-related mortality in patients with diabetes, researchers reported ...

Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for ...

Betty Remedios, 63, has a pep in her step as she gets out of the horizontal cylinder in which she’s been getting ...

PHILADELPHIA ( KYW) -- Police say a group of suspects traveled from New York City to Bucks County to carry out a targeted ...

Metformin is the first choice medicine for type 2 diabetes. Meglitinides can cause low blood sugar, weight gain, and headaches. Biguanides can cause stomach pain and might lead to vitamin B12 ...

Here's what San Antonio doctors say about the widespread use of GLP-1 medications for obesity, diabetes and other conditions.

In the past few months, court records show dozens of lawsuits filed by patients in Marion County against Indianapolis-based ...

New Medicare data shows which drugs cost the most, how many seniors take them, and why both volume and price matter for Part ...

New studies raise the possibility that GLP-1 medications beat aspirin in reducing colorectal cancer risk, and may improve outcomes for people who do develop the disease.

This is read by an automated voice. Please report any issues or inconsistencies here. After decades of public and self-imposed shame, Oprah credits a GLP-1 drug with silencing “food noise” — the ...